Jensen, J., Lundgren, B., Hein, L., Mohr, T., Petersen, P. L., Andersen, L. H., . . . Lundgren, J. D. (2008). The Procalcitonin And Survival Study (PASS) – A Randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker Procalcitonin and pro-active diagnostic and therapeutic responses to abnormal Procalcitonin levels, can improve survival in intensive care unit patients. Calculated sample size (target population): 1000 patients. BioMed Central.
Chicago Style citaatJensen, Jens-Ulrik, et al. The Procalcitonin And Survival Study (PASS) – A Randomised Multi-center Investigator-initiated Trial to Investigate Whether Daily Measurements Biomarker Procalcitonin and Pro-active Diagnostic and Therapeutic Responses to Abnormal Procalcitonin Levels, Can Improve Survival in Intensive Care Unit Patients. Calculated Sample Size (target Population): 1000 Patients. BioMed Central, 2008.
MLA citatieJensen, Jens-Ulrik, et al. The Procalcitonin And Survival Study (PASS) – A Randomised Multi-center Investigator-initiated Trial to Investigate Whether Daily Measurements Biomarker Procalcitonin and Pro-active Diagnostic and Therapeutic Responses to Abnormal Procalcitonin Levels, Can Improve Survival in Intensive Care Unit Patients. Calculated Sample Size (target Population): 1000 Patients. BioMed Central, 2008.